Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells

Neurosci Lett. 2001 Apr 13;302(1):58-62. doi: 10.1016/s0304-3940(01)01659-7.

Abstract

Although estrogen is known to exert beneficial effects on Alzheimer's disease, its underlying cellular mechanisms have not been clear. In this study we investigated whether or not neuroprotective effects of estrogen are mediated by estrogen receptors (ERs). Treatment of estrogen (1.8 nM) reduced beta-amyloid (Abeta)-induced death of ER-expressing W4 cells. This effect of estrogen was blocked by a specific ER blocker ICI 182,780. When estrogen was treated to HT22 cells, which lack functional ERs, Abeta-induced cell death was not affected. Transfection of HT22 cells with human ERalpha, but not ERbeta, restored protective action of estrogen against Abeta. Hoechst staining revealed that estrogen protected ERalpha-expressing cells by blocking Abeta-induced apoptosis. These results indicate that estrogen blocks Abeta-induced cell death via ERalpha-dependent pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Amyloid beta-Peptides / pharmacology
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Cell Death / drug effects
  • Cell Death / physiology
  • Cells, Cultured
  • Estradiol / analogs & derivatives*
  • Estradiol / pharmacology
  • Estrogen Antagonists / pharmacology
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Estrogens / pharmacology*
  • Fulvestrant
  • Humans
  • Neurons / drug effects*
  • Neurons / metabolism
  • Receptors, Estrogen / drug effects*
  • Receptors, Estrogen / metabolism
  • Transfection

Substances

  • Amyloid beta-Peptides
  • Estrogen Antagonists
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Estrogens
  • Receptors, Estrogen
  • Fulvestrant
  • Estradiol